ML Research Scientist - Computational Biologist/Bioinformatics
Merge Labs
Summary
Merge Labs is a frontier research lab with the mission of bridging biological and artificial intelligence to maximize human ability, agency and experience. We're pursuing this goal by developing fundamentally new approaches to brain-computer interfaces that interact with the brain at high bandwidth, integrate with advanced AI, and are ultimately safe and accessible for anyone to use.
Job description
About the team
Our Bio team designs, builds, and characterizes the biotechnologies that form the foundation of next-generation brain-computer interfaces. We combine molecular engineering, synthetic biology, neuroscience and advanced physical methods such as ultrasound to establish less invasive, high-bandwidth connections with neurons. The Bio team develops our core molecular technologies, validates their performance in vitro and in vivo, and demonstrates their advanced capabilities in animal models. We build custom experimental setups and pipelines and collaborate closely with engineers and data scientists. We work across disciplines to come up with creative ideas and solve some of the most challenging problems in biotechnology.
About the role
We're hiring a Senior / Principal Computational Biologist (Bioinformatics / Omics) to lead the design and deployment of large-scale omics pipelines, integrate multi-modal biological data, and collaborate with ML teams to uncover mechanistic and predictive insights. You'll architect data processing frameworks that convert raw omics data into clean, analysis-ready datasets and build ML-integrated pipelines that extract deeper meaning from this data. Over time, you'll help translate these into predictive frameworks that accelerate molecular engineering, inform experimental campaigns, and enable the discovery of highly functional molecules.
In this role, you will:
- Build the scientific and engineering scaffolding for bioinformatics and computational biology writ-large. Design, optimize, and maintain pipelines for genomics, transcriptomics, and proteomics data.
- Collaborate with wet-lab scientists to define tractable optimization objectives and encode domain specific priors and constraints.
- Prototype modeling frameworks using internal and public datasets; benchmark and validate performance.
- Serve to non-domain experts for democratization of first-principles analysis
- Stay up-to-date with the latest research in computational biology and prototype novel algorithms that can be deployed to improve the company's discovery or development workflows.
- Contribute to the long-term research roadmap and serve as a thought-leader for scientists.
You might thrive in this role if you have:
- Deep experience with omics data analysis (bulk and single-cell) and bioinformatics pipelines.
- Expertise in Python and/or R; fluency with workflow management tools (e.g. Nextflow / Dagster)
- Proficiency in Python / PyTorch / Jax and comfort writing clean, reproducible production grade code.
- Experience bridging computational biology and experimental science—working with sparse, noisy, and or high-cost data.
- A collaborative, systems-level mindset.
Nice to have
- Familiarity with neuroscience
- Familiarity with transfer-learning paradigms
Requirements
- Deep experience with omics data analysis (bulk and single-cell) and bioinformatics pipelines.
- Expertise in Python and/or R; fluency with workflow management tools (e.g. Nextflow / Dagster)
- Proficiency in Python / PyTorch / Jax and comfort writing clean, reproducible production grade code.
- Experience bridging computational biology and experimental science—working with sparse, noisy, and or high-cost data.
- A collaborative, systems-level mindset.
Benefits
- Equity
Company overview
Merge Labs is an innovative neurotechnology startup that emerged from stealth in 2025 with a mission to bridge biological and artificial intelligence through advanced brain-computer interface (BCI) technology. Co-founded by OpenAI CEO Sam Altman along with leading neuroscientists and technology entrepreneurs, the company has secured $252 million in seed funding at an $850 million valuation, with significant backing from OpenAI, Bain Capital, and other prominent investors. Merge Labs differentiates itself by pursuing non-invasive approaches using ultrasound technology combined with molecular tools and engineered proteins to read and modulate neural activity, avoiding the surgical risks associated with implanted devices like Neuralink's. The company's technology focuses on using focused ultrasound to detect changes in brain blood flow, enabling whole-brain access rather than localized measurements. With a team of 11-50 employees and strong affiliations with Forest Neurotech research organization, Merge Labs aims to develop interfaces that are "equal parts biology, device, and AI" to enhance human ability, agency, and experience while creating natural, thought-driven interactions with advanced AI systems.